ESTABLISHMENT OF A PRODUCTION PROCESS AND STABILITY ASSESSMENT OF RED BLOOD CELL REAGENT PANELS FOR QUALITY CONTROL OF ABO BLOOD GROUPING DEVICES
DOI:
https://doi.org/10.56086/jcvb.v6i3.266Keywords:
Red blood cell, Production of red blood cell, Stability of red blood cell, Homogeneity of red blood cellAbstract
Standard red blood cells expressing A or B antigens (or lacking antigens for group O) are essential for the quality control of ABO blood grouping medical devices. However, commercially available standard red blood cells produced by specialized manufacturers are often expensive, difficult to import, and dependent on external suppliers. This study aimed to establish an in-house production process for standard red blood cell panels of blood groups A, B, AB, and O for quality control purposes, and to evaluate their stability and homogeneity. Red blood cells were collected from donors whose blood groups had been determined and who tested negative for transfusion-transmissible infections, including HIV, HBV, and HCV. Blood grouping was confirmed using both forward and reverse methods. Red blood cells were separated from plasma by centrifugation, washed to remove impurities and other plasma proteins, suspended in a specialized preservative solution at a defined concentration, standardized to ensure batch-to-batch uniformity, and packaged. The results demonstrated that the process was feasible and reproducible, with the resulting red blood cells yielding strong and specific agglutination reactions. When stored at 2–8°C, the biochemical, hematological, and antigenic characteristics of the preparations remained stable for up to 28 days.
